Trial intelligence / Profile preview

Growth Hormone and Nutrition Therapy in Juvenile Crohn's Disease

NCT01647412Phase 2Withdrawn

Sponsor
Columbia University
Start
Mar 2012
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 2 trial of somatropin in Crohn's disease, sponsored by Columbia University. Planned start Mar 2012; status: withdrawn.

02

Drugs

somatropin
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT01647412.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01647412.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call